• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·CBDY
Share

Target Group Inc. Stocks

$ 0Last Updated 21.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 617026

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Target Group Inc. operates within the Canadian cannabis sector, managing the entire lifecycle from cultivation and processing to the distribution of carefully selected cannabis products for both adult medical and recreational consumers. Their extensive product portfolio encompasses traditional cannabis flower, vaporizer-compatible extract pods, and pre-rolls. They also offer a diverse array of innovative infused products, including K-cup compatible coffee and tea pods, beverages, edibles, and topical applications, in addition to a line of CBD wellness items. A notable proprietary product is "Wisp," a unique single-use, pre-measured pod and vaporizer system designed for consumers seeking to vaporize natural botanical herbs, including cannabis. Target Group holds a collaborative agreement with cGreen, Inc. for the manufacturing and distribution of "True Focus," a patent-pending THC antidote, across the United States, Europe, and the Caribbean regions. Further expanding its reach, the company also maintains distribution, collaboration, and licensing arrangements with Serious Seeds B.V. Originally incorporated in 2013, the entity underwent a name change from Chess Supersite Corporation to Target Group Inc. in July 2018. Its operational base is situated in Hamilton, Canada.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, unde

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026